James Matthew Peyton, M.B.,Ch.B.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intubation, Intratracheal | 22 | 2024 | 1303 | 3.120 |
Why?
|
| Laryngoscopy | 12 | 2023 | 686 | 2.740 |
Why?
|
| Laryngoscopes | 6 | 2023 | 126 | 2.570 |
Why?
|
| Airway Management | 14 | 2024 | 297 | 2.250 |
Why?
|
| Anesthesiology | 9 | 2024 | 1135 | 1.410 |
Why?
|
| Anesthesia | 6 | 2021 | 1590 | 1.120 |
Why?
|
| Ventilation | 1 | 2022 | 127 | 0.730 |
Why?
|
| Respiratory System | 3 | 2022 | 559 | 0.720 |
Why?
|
| Anesthetics, Local | 2 | 2023 | 1015 | 0.550 |
Why?
|
| Auscultation | 1 | 2016 | 36 | 0.520 |
Why?
|
| Respiration | 2 | 2023 | 1653 | 0.520 |
Why?
|
| Stethoscopes | 1 | 2016 | 30 | 0.510 |
Why?
|
| Laryngeal Masks | 4 | 2024 | 103 | 0.460 |
Why?
|
| Respiratory Tract Diseases | 1 | 2020 | 744 | 0.450 |
Why?
|
| Education, Medical, Continuing | 1 | 2019 | 830 | 0.450 |
Why?
|
| Respiration, Artificial | 3 | 2024 | 2709 | 0.440 |
Why?
|
| Video Recording | 4 | 2022 | 969 | 0.410 |
Why?
|
| Registries | 5 | 2024 | 8297 | 0.380 |
Why?
|
| Child | 24 | 2024 | 80564 | 0.350 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 1792 | 0.300 |
Why?
|
| Anesthesia, Local | 2 | 2023 | 276 | 0.290 |
Why?
|
| Propofol | 2 | 2024 | 606 | 0.270 |
Why?
|
| Pandemics | 4 | 2021 | 8703 | 0.250 |
Why?
|
| Pediatrics | 5 | 2024 | 3606 | 0.210 |
Why?
|
| Masks | 2 | 2023 | 209 | 0.210 |
Why?
|
| Bronchoscopy | 3 | 2023 | 909 | 0.180 |
Why?
|
| Anesthesia, General | 3 | 2023 | 1172 | 0.170 |
Why?
|
| Lidocaine | 1 | 2023 | 550 | 0.170 |
Why?
|
| Humans | 37 | 2024 | 765968 | 0.170 |
Why?
|
| Airway Obstruction | 1 | 2024 | 665 | 0.160 |
Why?
|
| Thorax | 1 | 2022 | 554 | 0.160 |
Why?
|
| Ventilators, Mechanical | 1 | 2020 | 291 | 0.150 |
Why?
|
| Emergencies | 1 | 2024 | 1223 | 0.140 |
Why?
|
| Wakefulness | 1 | 2024 | 1282 | 0.140 |
Why?
|
| Equipment Design | 3 | 2020 | 3481 | 0.140 |
Why?
|
| Vocal Cord Paralysis | 1 | 2020 | 275 | 0.140 |
Why?
|
| Infection Control | 2 | 2021 | 983 | 0.130 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2023 | 1019 | 0.130 |
Why?
|
| Videotape Recording | 1 | 2017 | 331 | 0.130 |
Why?
|
| Fiber Optic Technology | 1 | 2017 | 284 | 0.130 |
Why?
|
| Saxitoxin | 1 | 2015 | 65 | 0.120 |
Why?
|
| Infant | 12 | 2024 | 36386 | 0.120 |
Why?
|
| Hypnotics and Sedatives | 2 | 2021 | 1191 | 0.120 |
Why?
|
| Consensus | 2 | 2021 | 3202 | 0.110 |
Why?
|
| Heart Defects, Congenital | 2 | 2021 | 4697 | 0.110 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2021 | 1002 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3100 | 0.100 |
Why?
|
| United States Food and Drug Administration | 1 | 2021 | 1672 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3223 | 0.100 |
Why?
|
| Epinephrine | 1 | 2015 | 783 | 0.100 |
Why?
|
| Bupivacaine | 1 | 2015 | 432 | 0.100 |
Why?
|
| Trachea | 1 | 2016 | 1085 | 0.080 |
Why?
|
| Child, Preschool | 6 | 2024 | 42500 | 0.080 |
Why?
|
| Oxygen | 1 | 2021 | 4241 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2024 | 4863 | 0.080 |
Why?
|
| Aerosols | 2 | 2021 | 633 | 0.070 |
Why?
|
| Infant, Newborn | 6 | 2024 | 26346 | 0.070 |
Why?
|
| Lung | 2 | 2023 | 10033 | 0.070 |
Why?
|
| Retrospective Studies | 7 | 2024 | 81514 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 10383 | 0.060 |
Why?
|
| Manikins | 1 | 2024 | 251 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 26318 | 0.050 |
Why?
|
| Anesthetics, Intravenous | 1 | 2024 | 397 | 0.050 |
Why?
|
| Critical Care | 2 | 2023 | 2712 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2020 | 416 | 0.040 |
Why?
|
| Male | 10 | 2024 | 363698 | 0.040 |
Why?
|
| Lung Compliance | 1 | 2019 | 207 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2020 | 251 | 0.040 |
Why?
|
| Neuromuscular Blockade | 1 | 2019 | 146 | 0.040 |
Why?
|
| Female | 9 | 2024 | 396112 | 0.040 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 248 | 0.040 |
Why?
|
| Adult | 5 | 2024 | 223044 | 0.040 |
Why?
|
| Australia | 1 | 2020 | 1258 | 0.030 |
Why?
|
| Mouth | 1 | 2019 | 381 | 0.030 |
Why?
|
| Pharynx | 1 | 2019 | 436 | 0.030 |
Why?
|
| Adolescent | 5 | 2024 | 88835 | 0.030 |
Why?
|
| Tongue | 1 | 2019 | 405 | 0.030 |
Why?
|
| Leukemia | 1 | 2024 | 1522 | 0.030 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 1560 | 0.030 |
Why?
|
| Hypesthesia | 1 | 2015 | 106 | 0.030 |
Why?
|
| Skull | 1 | 2019 | 811 | 0.030 |
Why?
|
| Esophagus | 1 | 2020 | 1037 | 0.030 |
Why?
|
| Larynx | 1 | 2019 | 491 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2020 | 1441 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 1394 | 0.030 |
Why?
|
| Propensity Score | 1 | 2021 | 1968 | 0.030 |
Why?
|
| Incidence | 2 | 2021 | 21480 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 1846 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2019 | 2122 | 0.020 |
Why?
|
| Hospitals | 1 | 2021 | 3888 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2024 | 65188 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 6309 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2015 | 3561 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 10729 | 0.010 |
Why?
|
| United States | 2 | 2021 | 72903 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2015 | 12437 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2024 | 54802 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 24282 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 36532 | 0.010 |
Why?
|
| Risk Factors | 1 | 2021 | 74840 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 59889 | 0.000 |
Why?
|
| Middle Aged | 1 | 2021 | 223009 | 0.000 |
Why?
|